TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Turnaround Candidate or Racing to the Bottom?

    Valent Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is making all of the right business decisions, but it may not be enough to…

    Read more »

    The Motley Fool
    Investing

    Concordia International Corp.: A Safe Buy?

    Concordia International Corp. (TSX:CXR)(NASDAQ:CXRX) is a risky, debt-ridden company that could grow quite handsomely if a series of steps are…

    Read more »

    The Motley Fool
    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc.?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a risky buy, even if it can get its debt under control--and that's a…

    Read more »

    The Motley Fool
    Dividend Stocks

    3 Dirty Secrets Bay Street Doesn’t Want You to Know

    Be wary of what Bay Street bankers and analysts tell you, especially when they tout stocks such as Valeant Pharmaceuticals…

    Read more »

    The Motley Fool
    Investing

    More Problems for Valeant Pharmaceuticals Intl Inc.

    Problems continue to mount for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). The company now faces a number of lawsuits in addition…

    Read more »

    The Motley Fool
    Investing

    The Smart Money Is Buying Valeant Pharmaceuticals Intl Inc.: Should You Buy Too?

    Famed mutual fund manager Francis Chou is buying Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). What does he see in the troubled…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Recover From its Implosion?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) might seem like it's on its last breath, but it has made smart moves that…

    Read more »

    The Motley Fool
    Dividend Stocks

    How Will a Trump or Clinton Presidency Affect Your Portfolio?

    Do you own Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) or TransCanada Corporation (TSX:TRP)(NYSE:TRP) shares? Then pay attention to this election cycle.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: This Risky Stock Has Huge Upside

    After falling 90%, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has been written off for dead. But perhaps value investors might want…

    Read more »

    The Motley Fool
    Investing

    Has Valeant Pharmaceuticals Intl Inc. Hit the Bottom Yet?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may have lost over 90% in value over the past year, but the company continues…

    Read more »

    The Motley Fool
    Investing

    What Can Investors Expect From Valeant Pharmaceuticals Intl Inc.?

    Because of high debt, a money-losing partnership, and questions about whether or not insiders have faith, I say avoid Valeant…

    Read more »

    The Motley Fool
    Investing

    How Valeant Pharmaceuticals Intl Inc. Could Become a Great Investment

    Beleaguered Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is starting to make amends for the epic collapse of the stock over the…

    Read more »